Unusual dyspnea in a woman with CREST syndrome

Chest

Volumn 133, Issue 1, 2008, Pages 286-290

  Tzeng, David Z ^a   Leslie, Kevin O ^b   Shelton, David ^a   Chan, Andrew ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Bronchiolitis obliterans; Constrictive bronchiolitis; CREST syndrome; Scleroderma

Indexed keywords

ADULT; ARTICLE; BRONCHIOLITIS OBLITERANS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DYSPNEA; FEMALE; HUMAN; LUNG BIOPSY; PRIORITY JOURNAL; SYMPTOM; SYNDROME CREST; THORAX RADIOGRAPHY;

EID: 38349052060     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-1211     Document Type: Article

References (29)

1. Klippel JH, Crofford LJ, Stone JH, et al. Systemic sclerosis and related syndromes: epidemiology, pathology, and pathogenesis. In: Primer on the rheumatic diseases. Atlanta, GA: Arthritis Foundation, 2001; 353-364
2. Owens GR, Fino GJ, Herbert DL, et al. Pulmonary function in progressive systemic sclerosis: comparison of CREST syndrome variant with diffuse scleroderma. Chest 1983; 84:546-550
3. Steen VD. The lung in systemic sclerosis. J Clin Rheumatol 2005; 11:40-46
4. Thompson AE, Pope JE. A study of the frequency of pericardial and pleural effusions in scleroderma. Br J Rheumatol 1998; 37:1320-1323
5. Strange C, Highland KB. Interstitial lung disease in the patient who has connective tissue disease. Clin Chest Med 2004; 25:549-559
6. Bouros D, Wells AU, Nicholson AG, et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002; 1581-1586
7. Wells AU, Hansell DM, Haslam PL, et al. Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveolitis compared with the fibrosing alveolitis of systemic sclerosis. Am J Respir Crit Care Med 1998; 1474-1482
8. Mitri GM, Lucas M, Fertig N, et al. A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement. Arthritis Rheum 2003; 48:203-209
9. Jacobsen S, Halberg P, Ullman S, et al. A longitudinal study of pulmonary function in Danish patients with systemic sclerosis. Clin Rheum 1997; 16:384-390
10. Steen VD, Owens GR, Fino GJ, et al. Pulmonary involvement in systemic sclerosis (scleroderma). Arthritis Rheum 1985; 28:759-766
11. Bjerke RD, Tashkin DP, Clements PJ, et al. Small airways in progressive systemic sclerosis (PSS). Am J Med 1979; 66:201-209
12. McNearney TA, Reveille JD, Fischbach M, et al. Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors. Arthritis Rheum 2007; 57:318-326
13. Greenwald GI, Tashkin DP, Gong H, et al. Longitudinal changes in lung function and respiratory symptoms in progressive systemic sclerosis. Am J Med 1987; 83:83-92
14. Freemer MM, King TE. Connective tissue diseases. In: Interstitial lung disease. Hamilton, ON, Canada; BC Decker, 2003; 553-562
15. Harrison NK, Myers AR, Corrin R, et al. Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis 1991; 144:706-713
16. Gosink R, Friedman P, Liebow A. Bronchiolitis obliterans: roentgenologic-pathologic correlation. Am J Roentgenol Radium Ther Nucl Med 1973; 117:816-832
17. Colby TV, Leslie KO. Small airway lesions. In: Cagle PT, ed. Diagnostic pulmonary radiology. 1st ed. Lausanne, Switzerland: Marcel Dekker, 2000; 231-249
18. Colby TV. Bronchiolitis: pathologic considerations. Am J Clin Pathol 1998; 109:101-109
19. Epler GR, Snider GL, Gaensler EA, et al. Bronchiolitis and bronchitis in connective tissue disease: a possible relationship to the use of penicillamine. JAMA 1979; 242:528-532
20. Kraft M, Mortenson RL, Colby TV, et al. Cryptogenic constrictive bronchiolitis: a clinicopathologic study. Am Rev Respir Dis 1993; 148:1093-1101
21. Rossi SE, Erasmus JJ, McAdams HP, et al. Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics 2000; 20:1245-1259
22. Myers JL, Colby TV. Pathologic manifestations of bronchiolitis, constrictive bronchiolitis, cryptogenic organizing pneumonia, and diffuse panbronchiolitis. Clin Chest Med 1993; 14:611-622
23. Ryu JH, Myers JL, Swensen SJ. Bronchiolar disorders. Am J Respir Crit Care Med 2003; 168:1277-1292
24. Visscher DW, Myers JL. Bronchiolitis. Proc Am Thorac Soc 2006; 3:41-47
25. Boehler A, Vogt B, Speich R, et al. Bronchiolitis obliterans in a patient with localized scleroderma treated with D-penicillamine. Eur Respir J 1996; 9:1317-1319
26. D'Ovidio F, Mura M, Tsang M, et al. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation. J Thorac Cardiovasc Surg 2005; 129:1144-1152
27. Davis RD, Lau CL, Eubanks S, et al. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg 2003; 125:533-542
28. King TE. Miscellaneous causes of bronchiolitis: inhalational, infectious, drug-induced, and idiopathic. Semin Respir Crit Care Med 2003; 24:567-576
29. Stern EJ, Swensen SJ, Hartman TE, et al. CT mosaic pattern of lung attenuation: distinguishing different causes. AJR Am J Roentgenol 1995; 165:813-816